Stefano Ziccardi

20PUBLICATIONS
34CO-AUTHORS
Medical infection agents (incl. prions)Gene and molecular therapyComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Memory and attentionCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Apr 10, 2026
Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomes.

Stefano Ziccardi, Damiano Marastoni, Pietro Biasi

|May 01, 2025
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis.

Damiano Marastoni, Elisa Colato, Matteo Foschi

|Apr 23, 2025
Cluster analysis showed long-term cognition can be predicted by looking at regional grey matter atrophy in the first two years of multiple sclerosis course.

Stefano Ziccardi, Maddalena Guandalini, Francesco Crescenzo

|Nov 04, 2024
Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study.

Stefano Ziccardi, Francesco Crescenzo, Maddalena Guandalini

|Aug 28, 2024
The time to include cognition in the multiple sclerosis concept of progression independent from relapse activity is now.

Stefano Ziccardi, Maddalena Guandalini, Tom A Fuchs

Pageof 4